Muscle Atrophy clinical trials
12 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis.
- Metformin and Muscle Recovery
- FIT Exercise in 30d of ULLS-induced Muscle Disuse
- YOOMI: Effect of Gamified Physical Therapy Exercise Software on Inpatient Mobility
- Muscle Response to Different Amounts of Dietary Protein During Leg Immobilization
- A SkeleTal Muscle Recovery Intervention With Dietary Protein in Heart Failure
- Effect of Percussive Massage on Skeletal Muscle During Limb Immobilization
- C-Protein in Fatigue and Aging
- Effectiveness of AlloWrap® for the Reduction of Inflammation in ACDF Procedures
- Post Operative Use of Neuromuscular Electrical Stimulation (NMES) Device for ACLR Patients
- Targeting Oxidative Stress to Prevent Vascular and Skeletal Muscle Dysfunction During Disuse
- Sex-specific Determinants of Early-phase Recovery From Skeletal Muscle Disuse
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Muscle Atrophy” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.